With antibiotic discovery coming back into vogue, two groups have literally gone to ground to find new compounds produced by bacteria in the soil. Using designed-for-purpose screening systems, the teams identified two unknown antimicrobial peptides...
...testing for diabetic foot ulcers. It was not the first stumble for Agennix. Its predecessor, GPC Biotech AG... ...of Roche (SIX:ROG; OTCQX:RHBBY) Agennix AG (Xetra:AGX) Germany Cancer 2006 9% 60% Agennix merged with GPC Biotech AG...
...trial is expected to be complete in 2013. In 2007, Yakult did a deal with GPC Biotech AG... ...to ThermoDox, a doxorubicin encapsulated in heat-activated liposomes Ph III for liver cancer July 2007 GPC Biotech AG...
...of Clinical Oncology in conjunction with the American Association for Clinical Oncology meeting in Orlando. GPC Biotech... ...by Genentech Inc. , a unit of Roche (SIX:ROG, Basel, Switzerland), and elsewhere by Roche. GPC Biotech AG...
With antibiotic discovery coming back into vogue, two groups have literally gone to ground to find new compounds produced by bacteria in the soil. Using designed-for-purpose screening systems, the teams identified two unknown antimicrobial peptides...
...testing for diabetic foot ulcers. It was not the first stumble for Agennix. Its predecessor, GPC Biotech AG... ...of Roche (SIX:ROG; OTCQX:RHBBY) Agennix AG (Xetra:AGX) Germany Cancer 2006 9% 60% Agennix merged with GPC Biotech AG...
...trial is expected to be complete in 2013. In 2007, Yakult did a deal with GPC Biotech AG... ...to ThermoDox, a doxorubicin encapsulated in heat-activated liposomes Ph III for liver cancer July 2007 GPC Biotech AG...
...of Clinical Oncology in conjunction with the American Association for Clinical Oncology meeting in Orlando. GPC Biotech... ...by Genentech Inc. , a unit of Roche (SIX:ROG, Basel, Switzerland), and elsewhere by Roche. GPC Biotech AG...
